Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer.
Wu-Hao LinJian XiaoZi-Yi YeDa-Liang WeiXiao-Hui ZhaiRui-Hua XuZhao-Lei ZengHui-Yan LuoPublished in: Clinical epigenetics (2021)
Together, our study indicated that this methylation marker can serve as a potential biomarker for diagnosing and monitoring CRC.